Core Laboratories CLB Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Core Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Core Laboratories's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Core Laboratories's additional paid-in capital?
- Core Laboratories (CLB) reported additional paid-in capital of $115.22M in Q1 2026.
- How has Core Laboratories's additional paid-in capital changed year-over-year?
- Core Laboratories's additional paid-in capital increased by 1.5% year-over-year, from $113.57M to $115.22M.
- What is the long-term trend for Core Laboratories's additional paid-in capital?
- Over 3 years (2022 to 2025), Core Laboratories's additional paid-in capital has grown at a 2.5% compound annual growth rate (CAGR), from $102.25M to $110.25M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.